Our Mission
Advancing Cancer Diagnostics, Improving Lives
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems Expands Clinical Digital Pathology Portfolio with Multiple Launches at DPAI 2025
VISTA, California, December 9, 2025 – Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is driving the future of clinical diagnostics with another bold step forward in the digital transformation of pathology, launching the Aperio GT 180 DX scanner, Aperio CS5 DX scanner, and Aperio iQC DX software during the Digital Pathology and AI (DPAI) Congress in London.
Leica Biosystems Launches IVDR Certified CytoVision DX – Complete Clinical Cytogenetics Platform
VISTA, California, September 30, 2025 – Leica Biosystems is proud to announce the launch of CytoVision DX, a next-generation image capture, analysis, and case management system purpose-built for clinical cytogenetics laboratories.
Moffitt Cancer Center Partners with Leica Biosystems to Advance Digital Pathology Statewide
First large-scale program in the state lays foundation for AI applications and aims to enhance speed, precision and access in pathology services. TAMPA, Fla. and VISTA, Calif. (Sept. 25, 2025) — Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Moffitt Cancer Center…
Leica Biosystems at a Glance
150+ Years of Innovation
| 2012 - Present | New Era of Science & Technology |
| 2005 - 2011 | Global Expansion Accelerates |
| 1989 - 2004 | Structuring for Comprehensive Workflow |
| 1930 - 1988 | Novel Products Drive Company Growth |
| 1900 - 1930 | Microtomy Technology Advances Amidst Wartime Realities |
| 1872 - 1899 | The Creation of the Microtome and the Early Years of R. Jung GMBH |
About Danaher
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.